Filing Details
- Accession Number:
- 0001209191-12-028591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-16 13:00:00
- Reporting Period:
- 2012-05-14
- Filing Date:
- 2012-05-16
- Accepted Time:
- 2012-05-16 16:33:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1294596 | Nancy Wysenski | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-14 | 4,531 | $37.86 | 36,763 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 147,071 | $39.70 | 183,834 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 25,000 | $39.70 | 208,832 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-14 | 3,398 | $38.80 | 212,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-14 | 179,628 | $64.27 | 32,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-14 | 372 | $65.00 | 32,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2012-05-14 | 4,531 | $0.00 | 4,531 | $37.86 |
| Common Stock | Stock Option | Disposition | 2012-05-14 | 147,071 | $0.00 | 147,071 | $39.70 |
| Common Stock | Stock Option | Disposition | 2012-05-14 | 25,000 | $0.00 | 25,000 | $39.70 |
| Common Stock | Stock Option | Disposition | 2012-05-14 | 3,398 | $0.00 | 3,398 | $38.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 67,969 | 2012-05-02 | 2022-02-01 | No | 4 | M | Direct |
| 32,929 | 2010-03-09 | 2019-12-08 | No | 4 | M | Direct |
| 43,750 | 2010-03-09 | 2019-12-08 | No | 4 | M | Direct |
| 37,383 | 2011-05-03 | 2021-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Wysenski's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $64.27 (range $63.90 to $64.82).
- Ms. Wysenski undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
